Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Hoedemaeker

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 1999
Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution patternH J Dubbink, R F Hoedemaeker, T H van der Kwast, et al.
The Journal of Urology|November 17, 1998
Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancerJ B Rietbergen, A E Kruger, R F Hoedemaeker, et al.
Urology|October 6, 2000
Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsyA N Vis, M O Boerma, S Ciatto, et al.
Cancer|January 28, 1999
Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesionsR F Hoedemaeker, R Kranse, J B Rietbergen, et al.
The Canadian Journal of Urology|July 16, 2005
Features of prostate cancers detected during a prevalence screening round. The Rotterdam experienceTh H Van der Kwast, R Postma, R F Hoedemaeker, et al.
The Journal of Urology|February 25, 2000
Prostate cancer detection at low prostate specific antigenF H Schröder, I van der Cruijsen-Koeter, H J de Koning, et al.
Urology|August 11, 1998
Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening studyJ B Rietbergen, R Kranse, R F Hoedemaeker, et al.
Journal of the National Cancer Institute|August 2, 2001
Pathologic features of prostate cancer found at population-based screening with a four-year intervalR F Hoedemaeker, T H van der Kwast, R Boer, et al.
Journal of Clinical Pathology|April 30, 2003
Guidelines for processing and reporting of prostatic needle biopsiesTh H van der Kwast, C Lopes, C Santonja, et al.
BJU International|February 28, 2004
Consistency of prostate cancer grading results in screened populations across EuropeT H Van der Kwast, M J Roobol, M F Wildhagen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 1999
Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution patternH J Dubbink, R F Hoedemaeker, T H van der Kwast, et al.
The Journal of Urology|November 17, 1998
Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancerJ B Rietbergen, A E Kruger, R F Hoedemaeker, et al.
Urology|October 6, 2000
Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsyA N Vis, M O Boerma, S Ciatto, et al.
Cancer|January 28, 1999
Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesionsR F Hoedemaeker, R Kranse, J B Rietbergen, et al.
The Canadian Journal of Urology|July 16, 2005
Features of prostate cancers detected during a prevalence screening round. The Rotterdam experienceTh H Van der Kwast, R Postma, R F Hoedemaeker, et al.
The Journal of Urology|February 25, 2000
Prostate cancer detection at low prostate specific antigenF H Schröder, I van der Cruijsen-Koeter, H J de Koning, et al.
Urology|August 11, 1998
Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening studyJ B Rietbergen, R Kranse, R F Hoedemaeker, et al.
Journal of the National Cancer Institute|August 2, 2001
Pathologic features of prostate cancer found at population-based screening with a four-year intervalR F Hoedemaeker, T H van der Kwast, R Boer, et al.
Journal of Clinical Pathology|April 30, 2003
Guidelines for processing and reporting of prostatic needle biopsiesTh H van der Kwast, C Lopes, C Santonja, et al.
BJU International|February 28, 2004
Consistency of prostate cancer grading results in screened populations across EuropeT H Van der Kwast, M J Roobol, M F Wildhagen, et al.
Pageof 3